Compare Ascendis Pharma A/S (ASND) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Recursion Pharmaceuticals Inc — how do they compare? Ascendis Pharma A/S trades at $254.5 (market cap $16.67B), while Recursion Pharmaceuticals Inc trades at $3.35 (market cap $1.81B). The key difference: Ascendis Pharma A/S is far larger — about 9.2× Recursion Pharmaceuticals Inc's market cap, and Ascendis Pharma A/S is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| ASND | RXRX | |
|---|---|---|
Market Cap | $16.67B | $1.81B |
Sector | Health | Health |
52-Week High | $277.18 | $6.79 |
52-Week Low | $189.74 | $2.84 |
Enterprise Value | $17.04B | $1.33B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
